Literature DB >> 3157753

Enhancing effect of IFN-gamma on helper T cell activity and IL 2 production.

D Frasca, L Adorini, S Landolfo, G Doria.   

Abstract

A single injection of young murine immune interferon (IFN-gamma) in young (3 mo) or old (14 to 24 mo) mice 3 days before carrier-priming significantly enhances helper T cell activity of their spleen cells. Maximal enhancement is attained when IFN-gamma is injected once immediately before priming or for 4 consecutive days from the time of priming. Helper activity for anti-TNP antibody response was titrated in vitro by adding graded numbers of spleen cells from HRBC-primed mice of a given age to cultures containing a constant number of spleen cells from 3-mo-old normal mice and TNP-HRBC. When T cell-enriched spleen cells from HRBC-primed young or old mice, uninjected or injected with IFN-gamma, were separated by nylon wool filtration into passed (Thi) and adherent (Th2) cells, the helper activity of both T cell subpopulations was found to be enhanced by IFN-gamma injection. Helper activity of purified Th1 and Th2 cells was also increased by their in vitro preincubation with IFN-gamma. Furthermore, interleukin 2 (IL 2) production by mitogen-activated spleen cells from young and old mice is enhanced by addition of IFN-gamma to cultures. These data altogether indicate that IFN-gamma plays an important role in immunoregulation of helper T cell activity.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3157753

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Impairment in proliferation, lymphokine production and frequency distribution of mitogen-responsive and interleukin-2-producing cells in Hodgkin's disease.

Authors:  R N Damle; S H Advani; S G Gangal
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

2.  Recombinant human gamma interferon enhances in vitro activation of lymphocytes isolated from patients with acquired immunodeficiency syndrome.

Authors:  W Heagy; T B Strom; V E Kelley; J Collela; C Crumpacker; J M Williams; H M Shapiro; L Laubenstein; R Finberg
Journal:  Infect Immun       Date:  1989-11       Impact factor: 3.441

3.  Effect of subcutaneous thymopentin treatment in drug addicts with persistent generalized lymphadenopathy.

Authors:  W Barcellini; P L Meroni; D Frasca; C Sguotti; M O Borghi; C Uberti-Foppa; P Buzzetti; A Lazzarin; G Doria; M Moroni
Journal:  Clin Exp Immunol       Date:  1987-03       Impact factor: 4.330

4.  Examination of the inhibitory effects of interferon-gamma on interleukin-4-induced stimulation of resting B cells from NZB/NZW F1 mice.

Authors:  M Minoda; K Hamada; M Higashikawa; H Sugishima; M Funauchi; A Horiuchi
Journal:  Clin Exp Immunol       Date:  1989-10       Impact factor: 4.330

5.  Age-related resistance of C57BL/6 mice to Cryptococcus neoformans is dependent on maturation of NKT cells.

Authors:  Rebecca Blackstock; Juneann W Murphy
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

6.  Evidence that defective gamma interferon production in patients with primary immunodeficiencies is due to intrinsic incompetence of lymphocytes.

Authors:  R Paganelli; M R Capobianchi; B Ensoli; G P D'Offizi; J Facchini; F Dianzani; F Aiuti
Journal:  Clin Exp Immunol       Date:  1988-04       Impact factor: 4.330

7.  Astrocytes modulate the polarization of CD4+ T cells to Th1 cells.

Authors:  Eléonore Beurel; Laurie E Harrington; William Buchser; Vance Lemmon; Richard S Jope
Journal:  PLoS One       Date:  2014-01-28       Impact factor: 3.240

8.  In vivo stimulation and restoration of the immune response by the noninflammatory fragment 163-171 of human interleukin 1 beta.

Authors:  D Boraschi; L Nencioni; L Villa; S Censini; P Bossù; P Ghiara; R Presentini; F Perin; D Frasca; G Doria
Journal:  J Exp Med       Date:  1988-08-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.